KLRK1 and neoplasm: miR-34a functions as a repressor of ULBP2 by directly targeting its 3′-UTR (Figure 2), resulting in the repression of NKG2D-mediated immune surveillance in melanoma and enhanced tumor progression (Heinemann et al., 2012).